Skip to main content Skip to section navigation Skip to footer
Back to AchieveLifeSciences.com
Achieve Life Sciences, Inc. Investor Relations
  • Investors
  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
  • Financial Info
    • Overview
    • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Information

Press Releases

News & Events

News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 23, 2021 8:30am EST

Achieve Life Sciences to Host Key Opinion Leader Panel on Smoking and e-Cigarette Cessation

Nov 22, 2021 8:30am EST

Achieve Life Sciences Announces Phase 3 ORCA-2 Trial of Cytisinicline in Smoking Cessation Clears Final Review by Data Safety Monitoring Committee (DSMC)

Nov 09, 2021 4:05pm EST

Achieve Reports Financial Results for Third Quarter 2021 and Provides Update on Cytisinicline Development

Nov 04, 2021 8:30am EDT

Achieve Life Sciences Announces Participation in November Investor Conferences

Nov 02, 2021 8:30am EDT

Achieve Life Sciences Announces FDA Acceptance of IND Application for Cytisinicline’s Second Planned Indication for Nicotine E-cigarette Cessation

Oct 26, 2021 8:30am EDT

Achieve Life Sciences to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 9, 2021

Sep 15, 2021 5:30am EDT

Achieve Life Sciences to Participate in Upcoming Investor Conferences

Sep 14, 2021 5:30am EDT

Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 21st Annual Society for Research on Nicotine & Tobacco (SRNT-E) Virtual Conference

Sep 09, 2021 5:30am EDT

Achieve Life Sciences to Participate in Two Upcoming Investor Conferences

Aug 13, 2021 5:30am EDT

Achieve Life Sciences Announces Expansion of Cytisinicline Clinical Operations Team and Granting of Inducement Awards

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • …Page 17
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Achieve Life Sciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap